Keith D. Dawkins, EVP, Global Chief Med. Officer at BOSTON SCIENTIFIC CORP (BSX), sold 41,955 shares at $24.64 ($1.0M) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Seasonal sale ($1.0M) by EVP, Global Chief Med. Officer — this insider has traded BSX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.55 | 11,955 | $293K | 28.4% |
| 2 | $24.64 | 30,000 | $739K | 71.6% |
| Total | $24.61 avg | 41,955 | $1.0M | 100% |
| Filing → |
| BSX | SELL | 2013-11-25 | $1.7M | — | Filing → |